Myelocortical Multiple Sclerosis: A Rare Cortical Variant

Myelocortical MS (MCMS) is a rare histopathological subtype of MS characterized by demyelination predominantly in the spinal cord (myelo-) and cerebral cortex (-cortical), with relative sparing of the cerebral white matter. Identified through post-mortem studies, it accounts for ~10–12% of MS cases.

Clinical Features

  • Prominent cognitive impairment: Early and disproportionate deficits in memory, attention, executive function, processing speed (cortical demyelination).
  • Motor/sensory deficits: From spinal cord lesions (weakness, spasticity, sensory loss).
  • Less typical: Optic neuritis, brainstem symptoms, large white matter lesions on MRI.
  • Psychiatric symptoms: Depression, apathy, irritability (frontal cortical involvement).
  • Fatigue: Often severe, multifactorial.

Diagnostic Challenges

Standard MRI (optimized for white matter) may appear deceptively normal or show only spinal cord lesions. Cortical lesions are poorly visualized on conventional sequences.

Advanced Diagnostic Tools

  • 3T/7T MRI with specialized sequences: DIR (double inversion recovery), PSIR (phase-sensitive inversion recovery), MP2RAGE for cortical lesion detection.
  • CSF analysis: Oligoclonal bands, neurofilament light chain (axonal injury marker).
  • Evoked potentials: VEP, SSEP may reveal subclinical cortical/spinal pathway dysfunction.
  • Neuropsychological testing: Essential to document cognitive profile.

Treatment Considerations

  • No MCMS-specific trials; treatment extrapolated from general MS.
  • High-efficacy DMTs (anti-CD20, natalizumab, cladribine) theoretically advantageous for cortical pathology.
  • Symptomatic management crucial: cognitive rehab, fatigue optimization, mood treatment.
  • Rehabilitation: PT/OT for motor deficits; speech therapy if dysarthria.

Living with MCMS

  • Regular neurologist visits with cognitive screening (SDMT, BICAMS).
  • Advanced MRI monitoring at centers with cortical imaging expertise.
  • Lifestyle neuroprotection: exercise, Mediterranean diet, sleep, stress reduction.
  • Support groups for rare MS variants (e.g., via MS Society, online communities).
  • Stay informed: MCMS research is evolving rapidly.

Key Takeaway: MCMS highlights that MS is not solely a white matter disease. Cortical and spinal cord pathology drive disability in distinct ways. If your MRI looks "quiet" but cognition and spinal cord symptoms are prominent, advocate for advanced imaging and comprehensive assessment.

Multiple Sclerosis - Related Articles